Alvin Wong

7PUBLICATIONS
64CO-AUTHORS
Molecular targetsPredictive and prognostic markersPharmaceutical delivery technologiesImmunogenetics (incl. genetic immunology)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 05, 2025
A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell Carcinoma.

Sumanta K Pal, Alice Bernard-Tessier, Peter Grell

|Jun 21, 2024
Androgen Receptor Splice Variant 7 in Asian Patients With Metastatic Castration-Resistant Prostate Cancer.

Daniel Ang, Johan Chan, Whee Sze Ong

|Feb 01, 2024
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer.

Tanya Dorff, Lisa G Horvath, Karen Autio

|Nov 14, 2023
Global Registry of Acute Coronary Events Score Underestimates Post-Acute Coronary Syndrome Mortality among Cancer Patients.

Chieh-Yang Koo, Huili Zheng, Li-Ling Tan

|Jun 22, 2023
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.

Yiqing Huang, Joseph J Zhao, Yu Yang Soon

|Jun 10, 2022
Clinical Presentation of Immune-Related Endocrine Adverse Events during Immune Checkpoint Inhibitor Treatment.

Jenny Hui Ling Chieng, Zaw Win Htet, Joseph J Zhao

Pageof 2

Frequent Collaborators

2 joint publications

Yiqing Huang

2 joint publications

Sen Hee Tay

2 joint publications

Alice Bernard-Tessier

1 joint publications

Adrian Kee